TrovaGene Inc. (TROV) News Nov 20, 2014, 4:00 p.m.
Post# of 250601
Posted On: 11/21/2014 3:26:58 AM
TrovaGene Inc. (TROV) News Nov 20, 2014, 4:00 p.m.
MarketWatch News on TROV
No News currently available for TROV
Other News on TROV
TrovaGene's (TROV) CEO Antonius Schuh on Q3 2014 Results - Earnings Call Transcript 9:34 p.m. Nov. 6, 2014 - Seeking Alpha
10-Q: TROVAGENE, INC. 4:06 p.m. Nov. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
What's in Store for TrovaGene (TROV) This Earnings Season? - Analyst Blog 3:40 p.m. Nov. 5, 2014 - Zacks.com
Can The Uptrend Continue for TrovaGene (TROV)? - Tale of the Tape 7:49 a.m. Sept. 15, 2014 - Zacks.com
Increased Earnings Estimates Seen for TrovaGene (TROV): Can It Move Higher? - Tale of the Tape 7:47 a.m. Sept. 8, 2014 - Zacks.com
How TrovaGene (TROV) Stock Stands Out in a Strong Industry - Tale of the Tape 7:36 a.m. Sept. 4, 2014 - Zacks.com
Trovagene continues bull run 10:07 a.m. Aug. 29, 2014 - Seeking Alpha
TrovaGene (TROV) Jumps: Stock Rises 9.2% - Tale of the Tape 8:18 a.m. Aug. 26, 2014 - Zacks.com
Trovagene reports results from HPV clinical studies 11:30 a.m. Aug. 25, 2014 - Seeking Alpha
Can the Rally in TrovaGene (TROV) Shares Continue? - Tale of the Tape 7:32 a.m. Aug. 22, 2014 - Zacks.com
Trovagene up on no news 11:08 a.m. Aug. 18, 2014 - Seeking Alpha
TrovaGene (TROV) Worth Watching: Stock Rises 8.8% - Tale of the Tape 8:39 a.m. Aug. 18, 2014 - Zacks.com
TrovaGene (TROV) Sees Hammer Chart Pattern: Time to Buy? - Tale of the Tape 9:52 a.m. Aug. 12, 2014 - Zacks.com
TrovaGene's (TROV) CEO Antonius Schuh on Q2 2014 Results - Earnings Call Transcript 4:15 a.m. Aug. 9, 2014 - Seeking Alpha
10-Q: TROVAGENE, INC. 3:06 p.m. Aug. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Ophthotech (OPHT) Jumps: Stock Rises 24.5% - Tale of the Tape 7:51 a.m. May 21, 2014 - Zacks.com
Trovagene cf-NA interim results 10:55 a.m. May 20, 2014 - Seeking Alpha
TrovaGene (TROV) is Oversold: Can It Recover? - Tale of the Tape 9:23 a.m. May 20, 2014 - Zacks.com
Investors lose patience with Trovagene 3:03 p.m. May 16, 2014 - Seeking Alpha
Anthera Pharmaceuticals (ANTH) Jumps: Stock Rises 10.3% - Tale of the Tape 7:51 a.m. May 16, 2014 - Zacks.com
Press Releases on TROV
Trovagene Releases Clinical Study Results for the Detection and Monitoring of KRAS Mutations in Circulating Tumor DNA of Colorectal Cancer Patients 9:08 a.m. Nov. 20, 2014 - PR Newswire - PRF
Trovagene to Present at Upcoming Healthcare Conferences 8:15 a.m. Nov. 12, 2014 - PR Newswire - PRF
Trovagene, Inc. Announces Third Quarter 2014 Financial Results 4:05 p.m. Nov. 6, 2014 - PR Newswire - PRF
Trovagene Schedules Release of Third Quarter 2014 Financial Results and Investor Conference Call 7:10 a.m. Oct. 29, 2014 - PR Newswire - PRF
Clinical Study Using Trovagene's Precision Cancer Monitoring Platform Published in Cancer Discovery 7:10 a.m. Oct. 27, 2014 - PR Newswire - PRF
Trovagene to Present at 13th Annual BIO Investor Forum 3:30 p.m. Oct. 6, 2014 - PR Newswire - PRF
Clinical Performance of Trovagene's Precision Cancer Monitoring Platform Presented at Second Annual International ECD Medical Symposium 7:05 a.m. Oct. 1, 2014 - PR Newswire - PRF
Cancer Geneticist, Alberto Bardelli, Ph.D., Joins Trovagene's Scientific Advisory Board 7:05 a.m. Sept. 17, 2014 - PR Newswire - PRF
Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 7:24 a.m. Aug. 26, 2014 - PR Newswire - PRF
Clinical Results Presented for Trovagene's Urine-Based High-Risk HPV Assay. 7:05 a.m. Aug. 25, 2014 - PR Newswire - PRF
Trovagene Provides Update on Its Urine-Based HPV Test 7:05 a.m. Aug. 20, 2014 - PR Newswire - PRF
Leader in Targeted Drug Development, Peter Hirth, Ph.D., Joins Trovagene's Scientific Advisory Board 7:05 a.m. Aug. 12, 2014 - PR Newswire - PRF
Trovagene, Inc. Announces Second Quarter 2014 Financial Results 3:05 p.m. Aug. 7, 2014 - PR Newswire - PRF
Trovagene Schedules Release of Second Quarter 2014 Financial Results and Investor Conference Call 7:05 a.m. July 30, 2014 - PR Newswire - PRF
Trovagene Secures $15 Million in Debt Financing From Silicon Valley Bank and Oxford Finance 7:05 a.m. July 1, 2014 - PR Newswire - PRF
Trovagene Enters Into a Strategic Alliance with the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the Northwestern Medicine Developmental Therapeutics Institute 7:05 a.m. June 30, 2014 - PR Newswire - PRF
Trovagene Announces Clinical Collaboration with Dana-Farber Cancer Institute 7:00 a.m. June 16, 2014 - PR Newswire - PRF
Oncogene Mutation Signal in Urinary Cell Free DNA is Highly Correlated with Treatment Response 11:45 a.m. June 2, 2014 - PR Newswire - PRF
Trovagene to Present at Jefferies 2014 Global Healthcare Conference 3:05 p.m. May 28, 2014 - PR Newswire - PRF
Trovagene's Precision Cancer Monitoring Technology Referenced in Multi-Disciplinary Clinical Consensus Guidelines 8:00 a.m. May 28, 2014 - PR Newswire - PRF
MarketWatch News on TROV
No News currently available for TROV
Other News on TROV
TrovaGene's (TROV) CEO Antonius Schuh on Q3 2014 Results - Earnings Call Transcript 9:34 p.m. Nov. 6, 2014 - Seeking Alpha
10-Q: TROVAGENE, INC. 4:06 p.m. Nov. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
What's in Store for TrovaGene (TROV) This Earnings Season? - Analyst Blog 3:40 p.m. Nov. 5, 2014 - Zacks.com
Can The Uptrend Continue for TrovaGene (TROV)? - Tale of the Tape 7:49 a.m. Sept. 15, 2014 - Zacks.com
Increased Earnings Estimates Seen for TrovaGene (TROV): Can It Move Higher? - Tale of the Tape 7:47 a.m. Sept. 8, 2014 - Zacks.com
How TrovaGene (TROV) Stock Stands Out in a Strong Industry - Tale of the Tape 7:36 a.m. Sept. 4, 2014 - Zacks.com
Trovagene continues bull run 10:07 a.m. Aug. 29, 2014 - Seeking Alpha
TrovaGene (TROV) Jumps: Stock Rises 9.2% - Tale of the Tape 8:18 a.m. Aug. 26, 2014 - Zacks.com
Trovagene reports results from HPV clinical studies 11:30 a.m. Aug. 25, 2014 - Seeking Alpha
Can the Rally in TrovaGene (TROV) Shares Continue? - Tale of the Tape 7:32 a.m. Aug. 22, 2014 - Zacks.com
Trovagene up on no news 11:08 a.m. Aug. 18, 2014 - Seeking Alpha
TrovaGene (TROV) Worth Watching: Stock Rises 8.8% - Tale of the Tape 8:39 a.m. Aug. 18, 2014 - Zacks.com
TrovaGene (TROV) Sees Hammer Chart Pattern: Time to Buy? - Tale of the Tape 9:52 a.m. Aug. 12, 2014 - Zacks.com
TrovaGene's (TROV) CEO Antonius Schuh on Q2 2014 Results - Earnings Call Transcript 4:15 a.m. Aug. 9, 2014 - Seeking Alpha
10-Q: TROVAGENE, INC. 3:06 p.m. Aug. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Ophthotech (OPHT) Jumps: Stock Rises 24.5% - Tale of the Tape 7:51 a.m. May 21, 2014 - Zacks.com
Trovagene cf-NA interim results 10:55 a.m. May 20, 2014 - Seeking Alpha
TrovaGene (TROV) is Oversold: Can It Recover? - Tale of the Tape 9:23 a.m. May 20, 2014 - Zacks.com
Investors lose patience with Trovagene 3:03 p.m. May 16, 2014 - Seeking Alpha
Anthera Pharmaceuticals (ANTH) Jumps: Stock Rises 10.3% - Tale of the Tape 7:51 a.m. May 16, 2014 - Zacks.com
Press Releases on TROV
Trovagene Releases Clinical Study Results for the Detection and Monitoring of KRAS Mutations in Circulating Tumor DNA of Colorectal Cancer Patients 9:08 a.m. Nov. 20, 2014 - PR Newswire - PRF
Trovagene to Present at Upcoming Healthcare Conferences 8:15 a.m. Nov. 12, 2014 - PR Newswire - PRF
Trovagene, Inc. Announces Third Quarter 2014 Financial Results 4:05 p.m. Nov. 6, 2014 - PR Newswire - PRF
Trovagene Schedules Release of Third Quarter 2014 Financial Results and Investor Conference Call 7:10 a.m. Oct. 29, 2014 - PR Newswire - PRF
Clinical Study Using Trovagene's Precision Cancer Monitoring Platform Published in Cancer Discovery 7:10 a.m. Oct. 27, 2014 - PR Newswire - PRF
Trovagene to Present at 13th Annual BIO Investor Forum 3:30 p.m. Oct. 6, 2014 - PR Newswire - PRF
Clinical Performance of Trovagene's Precision Cancer Monitoring Platform Presented at Second Annual International ECD Medical Symposium 7:05 a.m. Oct. 1, 2014 - PR Newswire - PRF
Cancer Geneticist, Alberto Bardelli, Ph.D., Joins Trovagene's Scientific Advisory Board 7:05 a.m. Sept. 17, 2014 - PR Newswire - PRF
Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 7:24 a.m. Aug. 26, 2014 - PR Newswire - PRF
Clinical Results Presented for Trovagene's Urine-Based High-Risk HPV Assay. 7:05 a.m. Aug. 25, 2014 - PR Newswire - PRF
Trovagene Provides Update on Its Urine-Based HPV Test 7:05 a.m. Aug. 20, 2014 - PR Newswire - PRF
Leader in Targeted Drug Development, Peter Hirth, Ph.D., Joins Trovagene's Scientific Advisory Board 7:05 a.m. Aug. 12, 2014 - PR Newswire - PRF
Trovagene, Inc. Announces Second Quarter 2014 Financial Results 3:05 p.m. Aug. 7, 2014 - PR Newswire - PRF
Trovagene Schedules Release of Second Quarter 2014 Financial Results and Investor Conference Call 7:05 a.m. July 30, 2014 - PR Newswire - PRF
Trovagene Secures $15 Million in Debt Financing From Silicon Valley Bank and Oxford Finance 7:05 a.m. July 1, 2014 - PR Newswire - PRF
Trovagene Enters Into a Strategic Alliance with the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the Northwestern Medicine Developmental Therapeutics Institute 7:05 a.m. June 30, 2014 - PR Newswire - PRF
Trovagene Announces Clinical Collaboration with Dana-Farber Cancer Institute 7:00 a.m. June 16, 2014 - PR Newswire - PRF
Oncogene Mutation Signal in Urinary Cell Free DNA is Highly Correlated with Treatment Response 11:45 a.m. June 2, 2014 - PR Newswire - PRF
Trovagene to Present at Jefferies 2014 Global Healthcare Conference 3:05 p.m. May 28, 2014 - PR Newswire - PRF
Trovagene's Precision Cancer Monitoring Technology Referenced in Multi-Disciplinary Clinical Consensus Guidelines 8:00 a.m. May 28, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼